European Surveillance System on Contact Allergies (ESSCA): Characteristics of patients patch tested and diagnosed with irritant contact dermatitis.
RRID:SCR_001905
body site
eczema
epidemiology
irritant contact dermatitis
occupational contact dermatitis
patch testing
sensitization
Journal
Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950
Informations de publication
Date de publication:
17 Mar 2021
17 Mar 2021
Historique:
revised:
07
03
2021
received:
08
12
2020
accepted:
09
03
2021
pubmed:
18
3
2021
medline:
18
3
2021
entrez:
17
3
2021
Statut:
aheadofprint
Résumé
Irritant contact dermatitis (ICD) is caused by the acute locally toxic effect of a strong irritant, or the cumulative exposure to various weaker physical and/or chemical irritants. To describe the characteristics of patients with ICD in the population patch tested in the European Surveillance System on Contact Allergies (ESSCA; www.essca-dc.org) database. Data collected by the ESSCA in consecutively patch-tested patients from January 2009 to December 2018 were analyzed. Of the 68 072 patients, 8702 were diagnosed with ICD (without concomitant allergic contact dermatitis [ACD]). Hand and face were the most reported anatomical sites, and 45.7% of the ICD was occupational ICD (OICD). The highest proportions of OICD were found in metal turners, bakers, pastry cooks, and confectionery makers. Among patients diagnosed with ICD, 45% were found sensitized with no relevance for the current disease. The hands were mainly involved in OICD also in the subgroup of patients with contact dermatitis, in whom relevant contact sensitization had been ruled out, emphasizing the need for limiting irritant exposures. However, in difficult-to-treat contact dermatitis, unrecognized contact allergy, or unrecognized clinical relevance of identified allergies owing to incomplete or wrong product ingredient information must always be considered.
Sections du résumé
BACKGROUND
BACKGROUND
Irritant contact dermatitis (ICD) is caused by the acute locally toxic effect of a strong irritant, or the cumulative exposure to various weaker physical and/or chemical irritants.
OBJECTIVES
OBJECTIVE
To describe the characteristics of patients with ICD in the population patch tested in the European Surveillance System on Contact Allergies (ESSCA; www.essca-dc.org) database.
METHODS
METHODS
Data collected by the ESSCA in consecutively patch-tested patients from January 2009 to December 2018 were analyzed.
RESULTS
RESULTS
Of the 68 072 patients, 8702 were diagnosed with ICD (without concomitant allergic contact dermatitis [ACD]). Hand and face were the most reported anatomical sites, and 45.7% of the ICD was occupational ICD (OICD). The highest proportions of OICD were found in metal turners, bakers, pastry cooks, and confectionery makers. Among patients diagnosed with ICD, 45% were found sensitized with no relevance for the current disease.
CONCLUSIONS
CONCLUSIONS
The hands were mainly involved in OICD also in the subgroup of patients with contact dermatitis, in whom relevant contact sensitization had been ruled out, emphasizing the need for limiting irritant exposures. However, in difficult-to-treat contact dermatitis, unrecognized contact allergy, or unrecognized clinical relevance of identified allergies owing to incomplete or wrong product ingredient information must always be considered.
Identifiants
pubmed: 33729576
doi: 10.1111/cod.13833
pmc: PMC8360089
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Contact Dermatitis© 2021 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.
Références
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1516-1525
pubmed: 28627111
JAMA Dermatol. 2020 Jan 1;156(1):79-84
pubmed: 31774459
Contact Dermatitis. 2015 Mar;72(3):154-63
pubmed: 25639629
J Eur Acad Dermatol Venereol. 2017 Jun;31 Suppl 4:12-30
pubmed: 28656731
Contact Dermatitis. 2019 May;80(5):263-272
pubmed: 30520058
Clin Exp Dermatol. 2002 Mar;27(2):138-46
pubmed: 11952708
Br J Dermatol. 2006 Jul;155(1):104-9
pubmed: 16792760
J Dtsch Dermatol Ges. 2015 Jan;13(1):e1-22
pubmed: 25763418
Contact Dermatitis. 2012 Jul;67(1):9-19
pubmed: 22500724
J Invest Dermatol. 1966 Nov;47(5):375-92
pubmed: 5924293
Int Arch Occup Environ Health. 1999 Nov;72(8):496-506
pubmed: 10592001
J Eur Acad Dermatol Venereol. 2008 Feb;22(2):174-81
pubmed: 18211410
Contact Dermatitis. 1996 Feb;34(2):115-7
pubmed: 8681538
Contact Dermatitis. 2011 Dec;65(6):322-8
pubmed: 22077434
Br J Dermatol. 2016 Feb;174(2):319-29
pubmed: 26370659
J Invest Dermatol. 2003 Jul;121(1):37-40
pubmed: 12839561
Contact Dermatitis. 2018 Jun;78(6):373-385
pubmed: 29468728
Am J Clin Dermatol. 2002;3(4):283-9
pubmed: 12010073
Maedica (Bucur). 2011 Oct;6(4):277-81
pubmed: 22879841
Br J Dermatol. 2013 Feb;168(2):326-332
pubmed: 23039796
Acta Dermatovenerol Croat. 2013;21(3):180-4
pubmed: 24183222
J Eur Acad Dermatol Venereol. 2017 Apr;31(4):664-671
pubmed: 27896884
J Allergy Clin Immunol. 2013 Feb;131(2):300-13
pubmed: 22939651
Br J Dermatol. 2003 Sep;149(3):452-6
pubmed: 14510974
Contact Dermatitis. 2020 Jun;82(6):337-342
pubmed: 32037572
Contact Dermatitis. 2018 Sep;79(3):168-174
pubmed: 29845628
Contact Dermatitis. 2016 Sep;75(3):165-72
pubmed: 27199097
Contact Dermatitis. 2003 Nov;49(5):270-1
pubmed: 14996062
Contact Dermatitis. 1997 Nov;37(5):200-9
pubmed: 9412746
Clin Rev Allergy Immunol. 2019 Feb;56(1):99-109
pubmed: 30293200
Cutan Ocul Toxicol. 2020 Sep;39(3):213-222
pubmed: 32643443
Arch Dermatol Res. 1999 Oct;291(10):555-9
pubmed: 10552214
Mediators Inflamm. 2013;2013:916497
pubmed: 24371376
Contact Dermatitis. 2016 Aug;75(2):117-21
pubmed: 27385522
Contact Dermatitis. 2015 Oct;73(4):195-221
pubmed: 26179009
Contact Dermatitis. 2021 Mar 17;:
pubmed: 33729576
Contact Dermatitis. 1996 Oct;35(4):208-13
pubmed: 8957639